Association between myasthenia gravis and cognitive function: A systematic review and meta-analysis

Zhifeng Mao1, Junjie Yin1, Zhengqi Lu1

  • 1Department of Neurology, Multiple Sclerosis Center, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.

Insights

Myasthenia gravis (MG) patients often experience cognitive deficits, particularly in verbal learning and memory. While attention and visual memory appear preserved, overall cognitive function is impaired in MG.

Area of Science:

  • Neuroscience
  • Neurology
  • Cognitive Science

Background:

  • Myasthenia gravis (MG) is increasingly associated with cognitive dysfunction, suggesting potential central nervous system (CNS) involvement.
  • Existing research indicates cognitive impairments in both human patients and animal models of MG.

Purpose of the Study:

  • To systematically review and synthesize findings on the relationship between myasthenia gravis and cognitive function.
  • To identify specific cognitive domains affected in individuals with MG.

Main Methods:

  • A systematic review adhering to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.
  • Searched major databases for neuropsychological studies involving adult MG patients.
  • Pooled weighted effect sizes across eight identified cognitive domains.

Main Results:

  • Eight studies involving 300 subjects were analyzed.
  • Significant moderate effect sizes were observed in nine cognitive tasks, including MMSE, language, processing speed, verbal learning/memory (excluding delayed recall), and motor performance.
  • Verbal learning and memory emerged as the most significantly affected domain, while attention, response fluency, and visual learning/memory appeared relatively preserved.

Conclusions:

  • MG patients demonstrate significant cognitive impairments compared to controls across various domains.
  • Verbal logical-delayed memory, finger tapping, and the Symbol Digit Modalities Test showed the strongest associations with cognitive function in MG.
  • Findings highlight the impact of MG on cognitive abilities, though heterogeneity in studies necessitates cautious interpretation.

Related Concept Videos

Chemical Synapses01:26

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Chemical Synapses01:26

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...